TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
HCM

HUTCHMED DRC

Healthcare · Drug Manufacturers - Specialty & Generic

13.90$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

HUTCHMED DRC (HCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 550 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HCM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
87 178 216 241 214 205 228 356 426 838 630 550
59 111 156 176 144 160 189 29 311 384 348 337
28 67 60 65 70 45 40 327 115 454 283 213
30 47 67 76 116 92 177 299 387 303 213 164
13 20 22 24 31 39 50 89 92 80 64 67
47 77 107 119 163 197 238 684 834 436 326 267
-18 -9.8 -47 -53 -93 -153 -199 -357 -719 18 -44 -55
1.5 1.4 1.6 1.5 1.0 1.0 0.8 0.6 0.7 0.8 2.9 2.9
-4.8 12 19 -20 -67 -101 -111 -155 -361 106 45 523
1.3 1.6 4.3 3.1 4.0 3.3 4.8 12 -0.3 4.5 7.2 64
-33 8.0 12 -27 -75 -106 -126 -195 -361 101 38 458
-17 -7.8 -43 -50 -82 -135 -193 -155 -360 27 -31 -41

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?